- Future Meat claims a huge leap towards commercial viability for its lab-grown chicken, slashing production costs by almost half in just a few months.
- The company said it was now producing a 110 gramme chicken breast for just under $4, down from $7.50 announced at the start of the year.
- Future Meat is focused on gaining regulatory approval in the US and hopes to launch a product in the US market in the next 18 months that will have a commercially viable price.
- Alternative protein companies are racing to come up with a product that mimics conventional meat in taste while also competing on price.
- One of the big costs for cultivated meat companies has been the nutrient for the meat cells, and cutting the cost of this “feed” has been key to reducing the cost of production.
Lab-grown chicken start-up slashes production costs
Israel’s Future Meat pulls forward timetable for reaching price parity with real poultry
Emiko Terazono
/cloudfront-us-east-2.images.arcpublishing.com/reuters/RCWZE2OK3BNCJNRVFOS74NYF7M.jpg)
